Professor
University of Pittsburgh
Raman Venkataramanan, Ph.D; FACCP; FAAPS, is a Professor of Pharmaceutical Sciences and Pathology, Director of Clinical Pharmacokinetics laboratory and Director of Therapeutic Drug Monitoring and Toxicology at UPMC, Pittsburgh. He received his Bachelors in Pharmacy degree from University of Madras, India; Master of pharmacy from Birla Institute of Technology and Science, India; Doctorate from University of British Columbia, Canada. After a Postdoctoral fellowship at the University of Washington he joined as Faculty in the University of Pittsburgh in 1980. He is Special government employee in the Center for Drug Evaluation and Research, FDA.
He is an Editorial board member for Therapeutic Drug Monitoring journal, and four online journals. He is the Editor for the American Journal of Analytical Chemistry. He is a Reviewer for 10 additional journals
He is the Recipient of the following awards: Distingushed Investigator - 2024; Rho Chi Award for Outstanding Scholarly contributions 2022; Distinguished Service award, AAPS, 2021; Graduate Educator of the year award April 2021; Distinguished Scientists Award from AAiPS, Nov 2016
Graduate Faculty of the year award, School of Pharmacy (2015); Tyler Prize for Stimulation of Research (American Pharmacists Association [APhA], 2011)
Bristol-Meyers Squibb Mentorship in Clinical Pharmacology (American College of Clinical Pharmacy [ACCP], 2009); Provost’s Award for Excellence in Graduate Education (University of Pittsburgh, 2009); Innovations in Teaching award (Rho Chi Society at the University of Pittsburgh, 2009); Scholarly Contributions award (Rho Chi Society at the University of Pittsburgh, 2007); Ranbaxy Research Award in Pharmaceutical Sciences, 1998;
Distinguished Research Scientists Award, Institute of Kidney Disease, Ahmadabad, India; Orator – SLANT - First scientific session of the Sri Lanka Association of
Nephrology and Transplantation 1995.
The research in his laboratory revolves around “LIFE”. One half addresses, “prevention of preterm labor—giving life for the first time” by optimizing the use of 17-hydroxyprogesterone caproate during pregnancy and personalizing buprenorphine use during pregnancy; Second half addresses “optimization of use of medications in organ transplant patients—a second chance in life” and assessing the functional capacity of transplanted organs. He has received funding from NICHD for OBGYN pharmacology work for the past 18 years.
Presented more than 250 lectures/seminars at national/international meetings. Published over 450 papers in peer reviewed journals. Mentored over 50 graduate students and several fellows and faculty members.
